These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3277203)

  • 1. Extracorporeal plasma therapy: the HELP system for the treatment of hyper-beta-lipoproteinemia.
    Armstrong VW; Eisenhauer T; Noll D; Wieland H; Scheler F; Seidel D
    Prog Clin Biol Res; 1988; 255():327-35. PubMed ID: 3277203
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D
    Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal LDL elimination with immunabsorption or heparin precipitation: a comparison in 10 patients.
    Richter WO; Vierneisel K; Schwandt P
    Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2484766
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids].
    Loschiavo C
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experience.
    Eisenhauer T; Müller U; Schuff-Werner P; Armstrong VW; Bosch T; Thiery J; Gurland H; Seidel D
    ASAIO Trans; 1991; 37(3):M494-6. PubMed ID: 1751249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E; Mellwig KP; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal LDL elimination with immunoabsorption or heparin precipitation: a comparison in 10 patients.
    Richter WO; Vierneisel K; Schwandt P
    Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2461762
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia.
    Eisenhauer T; Schuff-Werner P; Armstrong VW; Talartschik J; Scheler F; Seidel D
    ASAIO Trans; 1987; 33(3):395-7. PubMed ID: 3675971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH
    Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
    [No Abstract]   [Full Text] [Related]  

  • 13. Six years of treatment with the HELP system of a patient with familial hypercholesterolemia.
    Nascimento MM; Pasqual DD; dos Santos JE; Riella MC
    Braz J Med Biol Res; 2002 Jul; 35(7):775-82. PubMed ID: 12131916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Schütz E; Seyde WC; Eisenhauer T; Janning G; Armstrong VW; Seidel D
    Eur J Clin Invest; 1989 Feb; 19(1):30-7. PubMed ID: 2499459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of low density lipoproteins (LDL) from plasma: the state of the art.
    Klinkmann H; Behm E; Ivanovich P
    Int J Artif Organs; 1989 Apr; 12(4):207-10. PubMed ID: 2656536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary familial hyper-alpha-lipoproteinemia in Israel].
    Raveh D; Israeli A; Gavish D; Eisenberg S
    Harefuah; 1986 Nov; 111(10):285-7. PubMed ID: 3817613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK; Li YX; Lei D; Wu DH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.
    Jaeger BR; Tsobanelis T; Bengel F; Schwaiger M; Seidel D
    J Pediatr; 2002 Jul; 141(1):125-8. PubMed ID: 12091863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.